{"id":145686,"date":"2025-03-03T17:19:07","date_gmt":"2025-03-03T11:49:07","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=145686"},"modified":"2025-03-03T17:19:11","modified_gmt":"2025-03-03T11:49:11","slug":"pharma-stock-jumps-3-after-lic-increases-its-stake-to-5-023-in-the-company","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-after-lic-increases-its-stake-to-5-023-in-the-company\/","title":{"rendered":"Pharma stock jumps 3% after LIC increases its stake to 5.023% in the company"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3523037599\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>This pharma stock engaged in manufacturing Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages, focusing on high-volume drugs globally, jumped 3 percent after increasing its stake to 5.023 percent in the company by Life Insurance Corporation of India (LIC).<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-737155540\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Stock Price Movement:<\/strong><\/h2><p>With a market capitalization of Rs. 11,473.59 crores, the share of <strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/GRANULES\" target=\"_blank\" rel=\"noreferrer noopener\">Granules India Limited<\/a><\/strong> has reached an intraday high of Rs. 474.95 per equity share, rising nearly around 2.90 percent from its previous day\u2019s close price of Rs. 461.55. Since then, the stock has retreated and is currently trading at Rs. 473.15 per equity share.\u00a0<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>What Happened:<\/strong><\/h2><p>Life Insurance Corporation of India (LIC) has acquired a 5.023 percent stake in Granules India Ltd. through a market purchase. The acquisition involved purchasing 1,21,82,570 shares, which increased their holding from 4.991 percent to 5.023 percent of the total voting capital of the company.&nbsp;<\/p><p>This represents an increase of 0.032 percent in LIC\u2019s total stake, reinforcing its position as a significant shareholder. As per the latest filling, this transaction was completed on February 27, 2025.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-1838444526\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Future Outlook:<\/strong><\/h2><p>The company management is confident about achieving a 20 percent compound annual growth rate (CAGR). They expect FY26 to show significant improvement over FY25, driven by new capacity coming online and expected European inspections.&nbsp;<\/p><p>Additionally, the company plans to spend around Rs. 500 crore on capital expenditure (Capex) in FY26, focusing on expanding its production capabilities to support growth.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Company Overview:<\/strong><\/h2><p>Granules India Limited was founded in 1984 and headquartered in Hyderabad, and is a vertically integrated pharmaceutical company. It develops, manufactures, and distributes active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), and finished dosages globally, specializing in high-volume drugs like paracetamol, ibuprofen, and metformin.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Recent quarter results and ratios:<\/strong><\/h2><p>Granules India Limited&#8217;s revenue has decreased from Rs. 1,156 crore in Q3 FY24 to Rs. 1,138 crore in Q3 FY25, which has dropped by 1.56 percent. The net profit has also decreased by 6.35 percent from Rs. 126 crore in Q3 FY24 to Rs. 118 crore in Q3 FY25.<\/p><p>Granules India Limited\u2019s revenue and net profit have grown at a CAGR of 14.61 percent and 11.41 percent, respectively, over the last five years.<\/p><p>In terms of return ratios, the company&#8217;s ROCE and ROE should be 15.4 percent and 13.4 percent, respectively. Granules India Limited has an earnings per share (EPS) of Rs. 19.8, and its debt-to-equity ratio is 0.32x.<\/p><div class=\"trade-content-10\" id=\"trade-2282931315\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written By &#8211; Nikhil Naik<\/strong><\/p><\/blockquote><p class=\"has-medium-font-size\"><strong>Disclaimer<\/strong><\/p><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on <a href=\"http:\/\/tradebrains.in\/\">tradebrains.in<\/a> are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><div class=\"trade-after-content\" id=\"trade-2394990233\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>This pharma stock engaged in manufacturing Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages, focusing on high-volume drugs globally, jumped 3 percent after increasing its stake to 5.023 percent in the company by Life Insurance Corporation of India (LIC). Stock Price Movement: With a market capitalization of Rs. 11,473.59 crores, the share [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":15408,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[4912,26657,18466,12738,948,936,3157],"class_list":["post-145686","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-granules-india","tag-granules-india-limited","tag-granules-india-news","tag-granules-india-share-price","tag-stock-market","tag-stock-market-news","tag-stock-to-watch"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock jumps 3% after LIC increases its stake to 5.023% in the company - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"This pharma stock engaged in manufacturing Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages, focusing on high-volume drugs globally, jumped 3 percent after increasing its stake to 5.023 percent in the company by Life Insurance Corporation of India (LIC).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-after-lic-increases-its-stake-to-5-023-in-the-company\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock jumps 3% after LIC increases its stake to 5.023% in the company\" \/>\n<meta property=\"og:description\" content=\"This pharma stock engaged in manufacturing Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages, focusing on high-volume drugs globally, jumped 3 percent after increasing its stake to 5.023 percent in the company by Life Insurance Corporation of India (LIC).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-after-lic-increases-its-stake-to-5-023-in-the-company\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-03T11:49:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-03T11:49:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/LIC-1-Cover-Image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-after-lic-increases-its-stake-to-5-023-in-the-company\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-after-lic-increases-its-stake-to-5-023-in-the-company\/\",\"name\":\"Pharma stock jumps 3% after LIC increases its stake to 5.023% in the company - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-after-lic-increases-its-stake-to-5-023-in-the-company\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-after-lic-increases-its-stake-to-5-023-in-the-company\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/LIC-1-Cover-Image.jpg\",\"datePublished\":\"2025-03-03T11:49:07+00:00\",\"dateModified\":\"2025-03-03T11:49:11+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"This pharma stock engaged in manufacturing Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages, focusing on high-volume drugs globally, jumped 3 percent after increasing its stake to 5.023 percent in the company by Life Insurance Corporation of India (LIC).\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-after-lic-increases-its-stake-to-5-023-in-the-company\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-after-lic-increases-its-stake-to-5-023-in-the-company\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-after-lic-increases-its-stake-to-5-023-in-the-company\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/LIC-1-Cover-Image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/LIC-1-Cover-Image.jpg\",\"width\":1280,\"height\":854,\"caption\":\"LIC 1 - Cover Image\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-after-lic-increases-its-stake-to-5-023-in-the-company\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock jumps 3% after LIC increases its stake to 5.023% in the company\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock jumps 3% after LIC increases its stake to 5.023% in the company - Trade Brains Features","description":"This pharma stock engaged in manufacturing Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages, focusing on high-volume drugs globally, jumped 3 percent after increasing its stake to 5.023 percent in the company by Life Insurance Corporation of India (LIC).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-after-lic-increases-its-stake-to-5-023-in-the-company\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock jumps 3% after LIC increases its stake to 5.023% in the company","og_description":"This pharma stock engaged in manufacturing Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages, focusing on high-volume drugs globally, jumped 3 percent after increasing its stake to 5.023 percent in the company by Life Insurance Corporation of India (LIC).","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-after-lic-increases-its-stake-to-5-023-in-the-company\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2025-03-03T11:49:07+00:00","article_modified_time":"2025-03-03T11:49:11+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/LIC-1-Cover-Image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-after-lic-increases-its-stake-to-5-023-in-the-company\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-after-lic-increases-its-stake-to-5-023-in-the-company\/","name":"Pharma stock jumps 3% after LIC increases its stake to 5.023% in the company - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-after-lic-increases-its-stake-to-5-023-in-the-company\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-after-lic-increases-its-stake-to-5-023-in-the-company\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/LIC-1-Cover-Image.jpg","datePublished":"2025-03-03T11:49:07+00:00","dateModified":"2025-03-03T11:49:11+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"This pharma stock engaged in manufacturing Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages, focusing on high-volume drugs globally, jumped 3 percent after increasing its stake to 5.023 percent in the company by Life Insurance Corporation of India (LIC).","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-after-lic-increases-its-stake-to-5-023-in-the-company\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-after-lic-increases-its-stake-to-5-023-in-the-company\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-after-lic-increases-its-stake-to-5-023-in-the-company\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/LIC-1-Cover-Image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/LIC-1-Cover-Image.jpg","width":1280,"height":854,"caption":"LIC 1 - Cover Image"},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-after-lic-increases-its-stake-to-5-023-in-the-company\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock jumps 3% after LIC increases its stake to 5.023% in the company"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/145686","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=145686"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/145686\/revisions"}],"predecessor-version":[{"id":145687,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/145686\/revisions\/145687"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/15408"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=145686"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=145686"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=145686"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}